Single article

DOI: 10.47026/2413-4864-2024-1-66-73

Lyubimova L.V., Pavlova S.I., Pchelova N.N., Lyubimov E.A.

The Use of a Polyvalent Klebsiella Bacteriophage in Infection after Reconstructive Plastic Surgery on the Spine in a Child (a clinical case)

Keywords: spinal infection, polyresistant Klebsiella pneumoniae, polyvalent Klebsiella bacteriophage, biofilms, spondylodesis

The incidence of infection after reconstructive plastic surgery on the spine (in particular, spondylodesis) in children remains at a fairly high level and ranges from 0.4% to 8.7%. These complications are often caused by polyresistant bacterial pathogens; this accentuates the need for new effective therapeutic approaches. Bacteriophage preparations in combination with antibiotics can optimize existing strategies for the treatment of infectious diseases, since they are able to selectively destroy bacteria, including biofilm-forming ones. The aim of the study was to draw the attention of practitioners to modern problems of treating polyresistant infections on the example of a case of purulent complication after spinal surgery in a child. Materials and methods. On the basis of the FSBI "Federal Center for Traumatology, Orthopedics and Endoprosthetics" under the Health Ministry of the Russian Federation (the town of Cheboksary) a retrospective analysis of a clinical case of treating early infection after reconstructive plastic surgery on the spine caused by a polyresistant strain of Klebsiella pneumoniae was conducted. Research results. Patient P., 2.2 years old, with congenital pathology of the musculoskeletal system, who repeatedly received medical care in various medical organizations, underwent surgical spine stabilization. In the early postoperative period, an infectious complication developed caused by a polyresistant strain of Klebsiella pneumoniae (a producer of extended-spectrum beta-lactamases and carbapenemases). Along with surgical debridement of the postoperative wound, a combined etiotropic antibacterial therapy was performed (12 weeks). However, complete healing of the postoperative wound was achieved in combination with the administration of a polyvalent klebsiella bacteriophage (10 weeks). Conclusions. This clinical case demonstrates that the use of a polyvalent klebsiella bacteriophage can increase the effectiveness of antibacterial pharmacotherapy in surgical treatment with preservation of metal structures.

References

  1. Alves D.R, Perez-Esteban P., Kot W. et al. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions. Microb Biotechnol., 2016, 9(1), pp. 61–74. DOI: 10.1111/1751-7915.12316.
  2. Bachy M., Bouyer B., Vialle R. Infections after spinal correction and fusion for spinal deformities in childhood and adolescence. Int Orthop., 2012, 36(2), pp. 465–469. DOI: 10.1007/s00264-011-1439-8.
  3. Cano E.J., Caflisch K.M., Bollyky P.L. et al. Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity. Clin Infect Dis., 2021, 73(1), pp. 144–151. DOI: 10.1093/cid/ciaa705.
  4. Clark C.E, Shufflebarger H.L. Late-developing infection in instrumented idiopathic scoliosis. Spine (Phila Pa 1976), 1999, 24(18), pp. 1909–1912. DOI: 10.1097/00007632-199909150-00008.
  5. Collins I., Wilson-MacDonald J., Chami G. et al. The diagnosis and management of infection following instrumented spinal fusion. Eur Spine J., 2008, 17(3), pp. 445–450. DOI: 10.1007/s00586-007-0559-8.
  6. Dedrick R.M., Guerrero-Bustamante C.A., Garlena R.A. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Med., 2019, vol. 25(5), pp. 730–733. DOI: 10.1038/s41591-019-0437-z.
  7. Doub J.B. Bacteriophage Therapy for Clinical Biofilm Infections: Parameters That Influence Treatment Protocols and Current Treatment Approaches. Antibiotics (Basel), 2020, vol. 9(11), p. 799. DOI: 10.3390/antibiotics9110799.
  8. Doub J.B., Tran J., Smith R. et al. Feasibility of Using Bacteriophage Therapy to Reduce Morbidity and Mortality Associated with Spinal Epidural Abscesses. Infect Chemother., 2023, vol. 55(2), pp. 257–263. DOI: 10.3947/ic.2022.0168.
  9. Ferry T., Kolenda C., Laurent F. et al. Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection. Nat Commun., 2022, vol. 13(1), p. 4239. DOI: 10.1038/s41467-022-31837-9.
  10. Hesse S., Malachowa N., Freedman B. et al. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258. mBio. 2021. Vol. 12(1), pp. e00034-21. doi: 10.1128/mBio.00034-21.
  11. Hernández-Jiménez E., Del Campo R., Toledano V. et al. Biofilm vs. planktonic bacterial mode of growth: which do human macrophages prefer? Biochem Biophys Res Commun., 2013, vol. 441(4), pp. 947–952. DOI: 10.1016/j.bbrc.2013.11.012.
  12. Ho C., Sucato D.J., Richards B.S. Risk factors for the development of delayed infections following posterior spinal fusion and instrumentation in adolescent idiopathic scoliosis patients. Spine (Phila Pa 1976), 2007, vol. 32(20), pp. 2272–2277. DOI: 10.1097/BRS.0b013e31814b1c0b.
  13. Khalifa L., Brosh Y., Gelman D. et al. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol., 2015, vol. 81(8), pp. 2696–2705. DOI: 10.1128/AEM.00096-15.
  14. Lamberet A., Violas P., Buffet-Bataillon S. et al. Postoperative Spinal Implant Infections in Children: Risk Factors, Characteristics and Outcome. Pediatr Infect Dis J., 2018, vol. 37(6), pp. 511–513. DOI: 10.1097/INF.0000000000001812.
  15. Leitner L., McCallin S., Kessler T.M. Bacteriophages: what role may they play in life after spinal cord injury? Spinal Cord., 2021, vol. 59(9), pp. 967– DOI: 10.1038/s41393-021-00636-2.
  16. Mohamed Ali M.H., Koutharawu D.N., Miller F. et al. Dabney K. Operative and clinical markers of deep wound infection after spine fusion in children with cerebral palsy. J Pediatr Orthop., 2010, vol. 30(8), pp. 851–857. DOI: 10.1097/BPO.0b013e3181f59f3f.
  17. Morris J., Kelly N., Elliott L. et al. Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus. Surg Infect (Larchmt), 2019, vol. 20(1), pp. 16–24. DOI: 10.1089/sur.2018.135.
  18. Nir-Paz R., Gelman D., Khouri A. et al. Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Infect. Dis., 2019, vol. 69(11), pp. 2015–2018. DOI: 10.1093/cid/ciz222.
  19. Schooley R.T., Biswas B., Gill J.J. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii Infection. Agents Chemother., 2017, vol. 61(10), pp. e00954–17. DOI: 10.1128/AAC.00954-17.
  20. Viola R.W., King H.A., Adler S.M., Wilson C.B. Delayed infection after elective spinal instrumentation and fusion. A retrospective analysis of eight cases. Spine (Phila Pa 1976), 1997, vol. 22(20), pp. 2444–2450; discussion 2450-1. DOI: 10.1097/00007632-199710150-00023.
  21. Clarke A.L., De Soir S., Jones J.D. The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review. Antibiotics (Basel). 2020, vol. 9(11), p. 795. DOI: 10.3390/antibiotics9110795.

About authors

Lyubimova Lyudmila V.
Clinical Pharmacologist, Federal Center for Traumatology, Orthopedics and Arthroplasty, Russia, Cheboksary (borisova-80@mail.ru; ORCID: https://orcid.org/0000-0002-5750-4459)
Pavlova Svetlana I.
Doctor of Medical Sciences, Head of the Department of Pharmacology, Clinical Pharmacology and Biochemistry, Chuvash State University, Russia, Cheboksary (flavonoid@yandex.ru; ORCID: https://orcid.org/0000-0001-9976-7866)
Pchelova Nadezhda N.
Doctor of Clinical Laboratory Diagnostics, Federal Center for Traumatology, Orthopedics and Arthroplasty, Russia, Cheboksary (nadyapchelova@mail.ru; ORCID: https://orcid.org/0000-0001-9507-9118)
Lyubimov Evgeniy A.
Anesthesiologist-Resuscitator, Federal Center for Traumatology, Orthopedics and Arthroplasty, Russia, Cheboksary (fc@orthoscheb.com; ORCID: https://orcid.org/0000-0001-5262-0197)

Article link

Lyubimova L.V., Pavlova S.I., Pchelova N.N., Lyubimov E.A. The Use of a Polyvalent Klebsiella Bacteriophage in Infection after Reconstructive Plastic Surgery on the Spine in a Child (a clinical case) [Electronic resource] // Acta medica Eurasica. – 2024. – №1. P. 66-73. – URL: https://acta-medica-eurasica.ru/en/single/2024/1/7/. DOI: 10.47026/2413-4864-2024-1-66-73.